• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国台州地区人乳头瘤病毒(HPV)18基因变异与宫颈癌风险

Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.

作者信息

Xu Hui-Hui, Zheng Ling-Zhi, Lin Ai-Fen, Dong Shan-Shan, Chai Ze-Ying, Yan Wei-Hua

机构信息

Laboratory of Gynecologic Oncology, Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Department of Gynecology and Obstetrics, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

出版信息

Gene. 2018 Mar 20;647:192-197. doi: 10.1016/j.gene.2018.01.037. Epub 2018 Jan 10.

DOI:10.1016/j.gene.2018.01.037
PMID:29331480
Abstract

Human papillomavirus (HPV) type 18 is predominantly associated with the development of cervical adenocarcinomas, whereas data on HPV18 genetic variability in China are limited. HPV18 genetic variants were formed phylogenetic tree, including lineages A, B, and C. We aimed to evaluate the diversity of HPV18 genetic variants by sequencing the entire E6, E7 and L1 genes. Between 2012 and 2015, a total of 138 (0.8%, 138/17669) women with single HPV18 infection were selected in this study. Finally, we observed 122 HPV18 isolates of the complete E6-E7-L1 sequences, and obtained 36 distinct variation patterns which the accession GenBank numbers as KY457805-KY457840. Except KY457805, KY457813, KY457819, KY457827, KY457829, the rest of HPV18 isolates (81.1%, 31/36) are novel variants. All of HPV18 variants belong to lineage A, while no lineage B, and C was found in our population of Taizhou region, Southeast China. Sublineage A1 was the most common variants (85.2%, 104/122), followed by sublineage A4, A3 and A5, while no sublineage A2 was obtained. Based on the tree topologies, there were three newly identified candidates' sublineages A6-A8. Out of 122 women, 67 (54.9%) had diagnosed by biopsy, including 49 women who diagnosed with cervicitis, 12 with cervical intraepithelial neoplasia (CIN)1, 4 with CIN2/3, and 2 with adenocarcinomas, respectively. Nevertheless, there was no association between HPV18 (sub) lineages and CIN1 or worse (CIN1+) lesions comparing with normal biopsies (P = .469). In conclusion, knowledge of the distribution of geographic/ethnical HPV18 genetic diversity provides critical information for developing diagnostic probes, epidemiologic correlate of cervical cancer risk and design of HPV vaccines for targeted populations.

摘要

18型人乳头瘤病毒(HPV)主要与宫颈腺癌的发生相关,而中国关于HPV18基因变异性的数据有限。HPV18基因变异形成了系统发育树,包括A、B和C谱系。我们旨在通过对整个E6、E7和L1基因进行测序来评估HPV18基因变异的多样性。2012年至2015年期间,本研究共选取了138例(0.8%,138/17669)单一HPV18感染的女性。最终,我们观察到122株HPV18完整E6-E7-L1序列的分离株,并获得了36种不同的变异模式,其GenBank登录号为KY457805-KY457840(原文此处表述有误,应为KY457805-KY457840)。除KY457805、KY457813、KY457819、KY457827、KY457829外,其余HPV18分离株(81.1%)为新变异株。所有HPV18变异株均属于A谱系,在中国东南部台州地区人群中未发现B和C谱系。A1亚谱系是最常见的变异株(85.2%,104/122),其次是A4、A3和A5亚谱系,未获得A2亚谱系。基于系统发育树拓扑结构,新鉴定出了三个候选亚谱系A6-A8。在122名女性中,67名(54.9%)经活检确诊,其中49名诊断为宫颈炎,12名诊断为宫颈上皮内瘤变(CIN)1级,4名诊断为CIN2/3级,2名诊断为腺癌。然而,与正常活检相比,HPV18(亚)谱系与CIN1或更严重(CIN1+)病变之间无关联(P = 0.469)。总之,了解地理/种族HPV18基因多样性的分布为开发诊断探针、宫颈癌风险的流行病学关联以及针对特定人群的HPV疫苗设计提供了关键信息。

相似文献

1
Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.中国台州地区人乳头瘤病毒(HPV)18基因变异与宫颈癌风险
Gene. 2018 Mar 20;647:192-197. doi: 10.1016/j.gene.2018.01.037. Epub 2018 Jan 10.
2
Genetic variability and oncogenic risk association of human papillomavirus type 58 E6 and E7 genes in Taizhou area, China.中国泰州地区人乳头瘤病毒 58 型 E6 和 E7 基因的遗传变异性与致癌风险关联。
Gene. 2019 Feb 20;686:171-176. doi: 10.1016/j.gene.2018.11.066. Epub 2018 Nov 22.
3
Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.韩国16型人乳头瘤病毒及其基因变异与宫颈病变的关联
APMIS. 2016 Nov;124(11):950-957. doi: 10.1111/apm.12592. Epub 2016 Aug 21.
4
Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.辽宁省宫颈病变妇女中 HPV58 型 E6、E7、L1 基因和长控制区的变异。
Infect Genet Evol. 2012 Oct;12(7):1466-72. doi: 10.1016/j.meegid.2012.05.004. Epub 2012 May 29.
5
Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China.基于 E6、E7 和 L1 基因的中国中部地区人乳头瘤病毒 18 型遗传变异。
Virol J. 2024 Jul 5;21(1):152. doi: 10.1186/s12985-024-02424-9.
6
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.中国泰州地区 HPV16 E6 和 E7 变异与宫颈癌发病风险的关联。
BMC Cancer. 2021 Jul 3;21(1):769. doi: 10.1186/s12885-021-08531-y.
7
Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation.韩国人乳头瘤病毒 18 型变异株中 15 个新的核苷酸替换:韩国 HPV18 变异株与临床表现。
Virol J. 2020 May 24;17(1):70. doi: 10.1186/s12985-020-01337-7.
8
Characteristics of Cervical Cancer Caused by the Human Papillomavirus 18 and Its Genetic Variations in Vietnamese Women.越南妇女人乳头瘤病毒 18 型所致宫颈癌的特征及其遗传变异。
Infect Genet Evol. 2024 Jan;117:105546. doi: 10.1016/j.meegid.2023.105546. Epub 2024 Jan 3.
9
Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.基于E6和L1基因的突尼斯宫颈病变女性人乳头瘤病毒(HPV)16和HPV18变体的系统发育与分类
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3361-3366. doi: 10.31557/APJCP.2018.19.12.3361.
10
Molecular epidemiology of human papillomavirus 18 infections in Japanese Women.人乳头瘤病毒 18 型在日本女性中的分子流行病学研究。
Infect Genet Evol. 2020 Sep;83:104345. doi: 10.1016/j.meegid.2020.104345. Epub 2020 Apr 28.

引用本文的文献

1
Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China.基于 E6、E7 和 L1 基因的中国中部地区人乳头瘤病毒 18 型遗传变异。
Virol J. 2024 Jul 5;21(1):152. doi: 10.1186/s12985-024-02424-9.
2
The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16.HPV 感染患者的转录组差异比 HPV16 的 E6 和 E7 基因突变更能促进宫颈癌的发生。
Medicine (Baltimore). 2024 Jan 19;103(3):e36822. doi: 10.1097/MD.0000000000036822.
3
Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro.
非精氨酸介导的 Anti-E6 ShRNA 递呈抑制 Hela 细胞体外生长。
Iran Biomed J. 2023 Nov 1;27(6):349-56. doi: 10.61186/ibj.3963.
4
Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China.中国东南部泰州 HPV33 E6 和 E7 基因变异与宫颈癌发病风险的关联。
Virol J. 2023 Jul 19;20(1):156. doi: 10.1186/s12985-023-02125-9.
5
Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China.中国河南省女性人乳头瘤病毒感染的特征及 HPV18 和 HPV58 的基因变异。
Sci Rep. 2023 Feb 8;13(1):2252. doi: 10.1038/s41598-022-24641-4.
6
Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia.沙特阿拉伯妇女中 HPV16 和 HPV18 的 E6、E7 和 L1 基因的遗传变异性。
Viruses. 2022 Dec 30;15(1):109. doi: 10.3390/v15010109.
7
Genetic variability in the E6 and E7 oncogenes of HPV52 and its prevalence in the Taizhou area, China.HPV52 型 E6 和 E7 致癌基因的遗传变异性及其在中国泰州地区的流行率。
Virol J. 2022 Nov 22;19(1):194. doi: 10.1186/s12985-022-01929-5.
8
Rapid and simultaneous visual typing of high-risk HPV-16/18 with use of integrated lateral flow strip platform.采用集成侧向流条带平台快速、同步目视判读高危型 HPV-16/18。
Mikrochim Acta. 2022 Aug 25;189(9):350. doi: 10.1007/s00604-022-05449-5.
9
Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation.韩国人乳头瘤病毒 18 型变异株中 15 个新的核苷酸替换:韩国 HPV18 变异株与临床表现。
Virol J. 2020 May 24;17(1):70. doi: 10.1186/s12985-020-01337-7.
10
Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse.在阿库塞的一项横断面研究中,自我采集的样本显示疫苗型和非疫苗型人乳头瘤病毒的流行率更高。
Adv Prev Med. 2020 Jan 22;2020:8343169. doi: 10.1155/2020/8343169. eCollection 2020.